260 related articles for article (PubMed ID: 18216759)
1. Drugs for lipids.
Treat Guidel Med Lett; 2008 Feb; 6(66):9-16. PubMed ID: 18216759
[No Abstract] [Full Text] [Related]
2. Drugs for lipids.
Treat Guidel Med Lett; 2005 Mar; 3(31):15-22. PubMed ID: 15726011
[No Abstract] [Full Text] [Related]
3. Fibrate therapy: safety considerations.
Usman M; Peter R
Curr Opin Lipidol; 2007 Dec; 18(6):702-4. PubMed ID: 17993818
[No Abstract] [Full Text] [Related]
4. When a statin fails.
Med Lett Drugs Ther; 2009 Jul; 51(1317):58-60. PubMed ID: 19636290
[No Abstract] [Full Text] [Related]
5. [LDL cholesterol in cardiovascular risk patients should be as low as possible].
MMW Fortschr Med; 2007 Oct; 149(41):44-5. PubMed ID: 17992793
[No Abstract] [Full Text] [Related]
6. LDL-Cholesterol is the King.
Goumas GS
Angiology; 2009; 60(3):387-8. PubMed ID: 19497926
[No Abstract] [Full Text] [Related]
7. Clinical trials and tribulations. Cholesterol veers off script.
Couzin J
Science; 2008 Oct; 322(5899):220-3. PubMed ID: 18845747
[No Abstract] [Full Text] [Related]
8. [Favorable effects of decreasing lipids in patients with diabetes mellitus].
Gouni-Berthold I; Krone W
Dtsch Med Wochenschr; 2006 Dec; 131 Suppl 8():S252-4. PubMed ID: 17139581
[TBL] [Abstract][Full Text] [Related]
9. [How can lipid therapy be improved? Cardiologists insist on dual cholesterol inhibition].
MMW Fortschr Med; 2005 Nov; 147(45):54. PubMed ID: 16320655
[No Abstract] [Full Text] [Related]
10. Is there evidence-based hypolipidemic treatment with clinical benefit beyond statins?
Goumas GS
Angiology; 2009; 60(1):93-8. PubMed ID: 19019838
[TBL] [Abstract][Full Text] [Related]
11. [Recommended LDL value far lower. How does one achieve this goal?].
Einecke D
MMW Fortschr Med; 2004 Mar; 146(13):6. PubMed ID: 15219116
[No Abstract] [Full Text] [Related]
12. [Hyperlipidemia: decreasing lipid values and effects of statins].
Mathes P
Z Kardiol; 2002; 91 Suppl 2():25-9. PubMed ID: 12436762
[No Abstract] [Full Text] [Related]
13. CEPHEUS Trial.
Moulin P
Arch Cardiovasc Dis; 2008 Sep; 101(9):513-4. PubMed ID: 19041834
[No Abstract] [Full Text] [Related]
14. [Dyslipidemia management in patients with impaired glucose tolerance].
Asano M; Yamada N
Nihon Rinsho; 2005 Feb; 63 Suppl 2():538-42. PubMed ID: 15779437
[No Abstract] [Full Text] [Related]
15. [Ezetimib as combination partner in hypercholesteremia. Lowering LDL beyond the effect of statins].
Sudhop T; von Bergmann K
MMW Fortschr Med; 2003 Apr; 145(16):48-50. PubMed ID: 14606402
[No Abstract] [Full Text] [Related]
16. Strategies for reducing cardiovascular risk in patients with hypertriglyceridemia.
Gorkin JU; Watson K; Knopp RH
J Fam Pract; 2007 Aug; 56(8 Suppl Strategies):S1-7; quiz S8. PubMed ID: 18667138
[No Abstract] [Full Text] [Related]
17. A summary of implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1329-30. PubMed ID: 15297284
[No Abstract] [Full Text] [Related]
18. Effects of nicotinic acid and lovastatin in combination with cholestyramine in renal transplant patients.
Lal SM; Katyal A
Mo Med; 2002; 99(10):580-4. PubMed ID: 12534147
[TBL] [Abstract][Full Text] [Related]
19. [Controlling LDL cholesterol from 2 sides. "I have never seen such low LDL values"].
MMW Fortschr Med; 2003 May; 145(20):59. PubMed ID: 12822234
[No Abstract] [Full Text] [Related]
20. Is there a problem with ezetimibe or just ENHANCEd hype?
Whayne TF
Angiology; 2008 Dec-2009 Jan; 59(6):661-3. PubMed ID: 18796445
[No Abstract] [Full Text] [Related]
[Next] [New Search]
